The Fc and glycoengineered antibodies market offers promising opportunities driven by a robust pipeline, significant interest in oncological applications, and technological advancements. With numerous ...

Oral Presentation October 29, 2025, 11:20-11:29am PST MGFA Scientific Session Topline Results from MaGic, a Phase 2 Trial of Claseprubart (DNTH103), an Active C1s Inhibitor, in Generalized Myasthenia ...

Abselion launches Protein G antibody kit for its Amperia platform, expanding flexible, accurate antibody quantification ...

The Neuromuscular Disease Therapeutics Market is entering a period of accelerated growth, supported by breakthroughs in gene ...

Active LN and the presence of U1-RNP antibodies were linked to low BMD and osteoporosis among patients with SLE.

France's Ose Immunotherapeutics will enrol up to 400 patients for the first two stages of clinical trials of an experimental coronavirus vaccine it hopes will provide an extra weapon in battle against ...

Chugai launches PiaSky in Taiwan for treatment of paroxysmal nocturnal hemoglobinuria: Tokyo Friday, October 3, 2025, 10:00 Hrs [IST] Chugai Pharmaceutical Co., Ltd. announced tha ...

Researchers at the First Affiliated Hospital of the University of Science and Technology of China claim that an in vivo CD8 T ...

For neuromyelitis optica spectrum disorder, long-term follow-up with a second-generation complement inhibitor shows an ...

Catalent’s preclinical study results provide proof-of-concept support for leveraging certepetide-related biology through its use as an ADC payload ...

Sue McCarthy shares her experience overcoming stage 3B lung cancer, reflecting on the impact of her diagnosis. After ...

Countries straining to contain a second wave of COVID-19 are turning to faster, cheaper but less accurate tests to avoid the delays and shortages that have plagued efforts to diagnose and trace those ...